neoantigen directed shared T-Cell Therapy (Adaptive Biotechnologies/Genentech)

N/A

Report date: 2025/06/11 11:12:03

Base Information

Drug Nameneoantigen directed shared T-Cell Therapy (Adaptive Biotechnologies/Genentech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocytes stimulantsImmunostimulantsHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdaptive Biotechnologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesAdaptive Biotechnologies CorpGenentech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A